Stock Information
Supernus Pharmaceuticals Inc (SUPN)
Ticker Symbol: SUPN
Exchange: NASDAQ
Sector: Pharmaceuticals
Market Cap: $2,894.49 mil
Piotroski score: 4
PE Ratio: N/A
EPS (TTM): -0.6838
Revenue (TTM): $12.52 M
Dividend Yield: N/A%
ROE: -3.67%
Latest News
-
Supernus Pharmaceuticals to Participate in the Bank of America 2026 Health Care Conference
Wed, May 6, 2026 5:01 PM
-
Supernus Pharmaceuticals, Inc. (SUPN) Q1 2026 Earnings Call Transcript
Tue, May 5, 2026 10:21 PM
-
Transcript : Supernus Pharmaceuticals, Inc., Q1 2026 Earnings Call, May 05, 2026
Tue, May 5, 2026 10:05 PM
-
Supernus Pharmaceuticals (NASDAQ:SUPN) Beats Q1 Estimates as Growth Products Drive 39% Revenue Surge
Tue, May 5, 2026 9:02 PM
-
Supernus Pharmaceuticals Q1 2026 Earnings Call Transcript
Tue, May 5, 2026 5:30 PM
-
Supernus: Q1 Earnings Snapshot
Tue, May 5, 2026 4:44 PM
-
Supernus Pharmaceuticals Affirms FY2026 Sales Guidance of $840.000M-$870.000M vs $862.242M Est
Tue, May 5, 2026 4:08 PM
-
Supernus Announces First Quarter 2026 Financial Results
Tue, May 5, 2026 4:07 PM
-
Supernus Pharmaceuticals Q1 EPS $(0.04) Misses $(0.01) Estimate, Sales $207.705M Beat $192.918M Estimate
Tue, May 5, 2026 4:07 PM
-
Earnings Scheduled For May 5, 2026
Tue, May 5, 2026 7:12 AM
Key Financials
Financial data not available
